Xaloc, Perdigó's new preliminary IPS design, at Respiratory Drug Delivery 2023

Comunicació,


Perdigó, design and engineering house for medical products, equipment and technology, and a CataloniaBio & HealthTech member, has recently unveiled Xaloc, the preliminary design for a dual-strip Dry Powder Inhaler (DPI), which is available for the development of both generic and innovator combination products.

The next stop for this new design is the Respiratory Drug Delivery conference, to be held in Antibes, France, on 2-5 May. The event is recognised as one of the leading international meetings in this field, focusing on pulmonary and nasal drug delivery. 

“As leaders in inhaler device design and development, we look forward to attending presentations from Presspart and Hovione, Aptar, Lonza, Honeywell, and more”, says the company. Arnau Perdigó and Marc Aliana will attend this year’s conference.

Comments


To comment, please login or create an account
Modify cookies